SEC Form 4 · accession 0001140361-18-024760
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard A Meier
Director
Period of report
May 17, 2018
Accepted (ET)
May 18, 2018 · 6:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 17, 2018 | M | 15,000 | $38.59 | A | 51,310 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) Common StockF1 | $38.59 | May 17, 2018 | M | 15,000 | D | Nov 22, 2008 | May 21, 2018 | Common Stock | 15,000 | 0 | D |
Explanation of responses
- F1Reflects the number of options outstanding after the transactions from this specific stock option grant.